PCI

Artikelen filtered by tag "PCI"

The following articles contain the tag PCI:


CYP2C19-genotyping for clopidogrel after percutaneous coronary intervention (PCI)

For patients with a fully or partially inactive CYP2C19 enzyme, treatment with ticagrelor or prasugrel for up 12 months after stent placement does not significantly reduce the total number of cases of cardiovascular mortality, myocardial infarcti ...

In short Read article


Genotyping prior to clopidogrel treatment?

Clopidogrel, which is used as a platelet aggregation inhibitor for the prophylaxis of atherothrombotic complications, is enzymatically activated by the enzyme CYP2C19. Patients whose genetic predisposition prevents or reduces the production of th ...

In short Read article